BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

11 articles for AL Parrill

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Highly Potent Non-Carboxylic Acid Autotaxin Inhibitors Reduce Melanoma Metastasis and Chemotherapeutic Resistance of Breast Cancer Stem Cells.EBI
University of Tennessee Health Science Center
Autotaxin inhibition: development and application of computational tools to identify site-selective lead compounds.EBI
The University of Memphis
Pharmacophore development and application toward the identification of novel, small-molecule autotaxin inhibitors.EBI
The University of Memphis
Synthesis and pharmacological evaluation of the stereoisomers of 3-carba cyclic-phosphatidic acid.EBI
University of Tennessee Health Science Center
Characterization of non-lipid autotaxin inhibitors.EBI
The University of Memphis
Structure-based drug design identifies novel LPA3 antagonists.EBI
The University of Memphis
Optimization of a pipemidic acid autotaxin inhibitor.EBI
The University of Memphis
Identification of non-lipid LPA3 antagonists by virtual screening.EBI
The University of Memphis
Synthesis and pharmacological evaluation of second-generation phosphatidic acid derivatives as lysophosphatidic acid receptor ligands.EBI
University of Tennessee Health Science Center
Molecular models of N-benzyladriamycin-14-valerate (AD 198) in complex with the phorbol ester-binding C1b domain of protein kinase C-delta.EBI
University of Tennessee College of Medicine
Discovery and synthetic optimization of a novel scaffold for hydrophobic tunnel-targeted autotaxin inhibition.EBI
University of Memphis